Professional technology integration to support the entire R&D process

Kinase assay development aims to establish accurate and stable in vitro analytical methods for assessing kinase activity and its inhibition by small molecules or biologics, a core step in targeted kinase drug discovery. The core principle of kinase assays is monitoring the phosphorylation of substrates (usually peptides or proteins) by kinases. Depending on the research objective and stage, development pathways are mainly divided into biochemical level assays (high-purity enzymes and substrates) and cellular level assays (cell lysates or live cells). A successful development process needs to balance throughput, sensitivity, physiological relevance, and resistance to interference, laying the foundation for subsequent optimization and validation.

1.Target and Objective Definition

Target Kinase: Identify the target kinase and its subtypes, focusing on structural features such as its ATP-binding pocket, activation loop, and substrate specificity.

Detection Objective: Determine the assay format.

Primary High-Throughput Screening: Requires homogeneity, high sensitivity, and ease of automation; biochemical homogeneous luminescence/fluorescence assays are usually preferred.

Mechanism of Action and Selectivity Studies: This may require multi-parameter assays (e.g., enzyme kinetics, competitive binding) or the use of specific mutants/tool ​​compounds.

Cellular Pathway Activity Assessment: Cellular-level assays are required to monitor the phosphorylation of downstream signaling proteins by endogenous kinases.

2.Reaction System Design and Construction

Biochemical Assay System:

Enzyme Source: Use recombinant kinases (full-length or catalytic domain). Specific activity, stability, and storage conditions must be evaluated.

Substrate Selection: Use universal substrates (e.g., Poly(Glu, Tyr)) or specific peptide/protein substrates. Optimize substrate concentrations to near the Km value to ensure the signal is sensitive to inhibitors.

Reaction Condition Optimization: Optimize the system buffer (pH, ionic strength, Mg²⁺/Mn²⁺ concentration), ATP concentration (usually near the Km value to screen for ATP-competitive inhibitors), DMSO tolerance, reaction time, and temperature.

Cellular Assay System:

Cell Model: Select cell lines that endogenously overexpress the target kinase or engineered cell lines that stably express it. The basic activity and inducibility of the kinase need to be verified.

Stimulation and Ligation: Optimize cellular stimulation conditions (e.g., growth factors, stress) to activate the target kinase and optimize the lysis buffer formulation to maintain phosphorylation.

Detection Target: Identify the downstream phosphorylation targets to be detected (e.g., AKT on Ser473, ERK1/2 on Thr202/Tyr204).

3.Detection Method Development and Optimization

Detection Technology Selection: Select an appropriate technology platform based on the assay level and detection target (see the table in Part II for details).

Key Parameter Optimization:

Signal Dynamic Range: Maximize the ratio of phosphorylation signal to background (enzyme-free control) by titrating enzyme amount, substrate, ATP, etc.

Linear Range: Ensure that the signal is linearly related to enzyme concentration or time within the selected reaction time.

Control Setup: A positive control (maximum enzyme activity, usually without inhibitor), a negative control (enzyme-free or using an inactivating mutant), and a background control (substrate-free or using a validated potent inhibitor, such as Staurosporine) must be established.

4.Interference Elimination and Analytical Method Establishment

Compound Interference Testing:Evaluate the potential interference of test compounds at high concentrations on the detection signal (e.g., fluorescence quenching, absorption, or direct effect on the detection enzyme).

Data Analysis: Establish dose-response curves and calculate IC₅₀, Ki, and enzyme kinetic parameters (Km, Vmax). For cellular assays, calculate the ratio of phosphorylation level to total protein or the percentage of inhibition.

Challenge 1: Detection Sensitivity of ATP Competitive Inhibitors

Solution: Use ATP concentrations close to their Km values ​​in the reaction to improve detection sensitivity for ATP competitive inhibitors. ATP titration can be performed to determine the optimal screening concentration.

Challenge 2: Fluorescence/Quenching Interference from Compound Libraries

Solution: Prioritize non-optical detection methods (e.g., ADP-Glo™) or ratiometric/time-resolved detection (e.g., TR-FRET) to reduce interference. Compound interference control wells (containing the compound but not the enzyme/assay reagent) must be included.

Challenge 3: Ensuring Assay Specificity (Off-Target Effects) 

Solution:

Enzyme Level: Verify the specificity of signal inhibition using selective tool inhibitors; verify binding patterns using kinase mutants (e.g., "gatekeeper" mutations).

At the cellular level: Use RNA interference or CRISPR to knock out target kinases and verify the downregulation of phosphorylation signals; use orthogonal detection methods (such as mass spectrometry phosphorylomics) to confirm pathway specificity.

Challenge 4: Instability of phosphorylation signals in cellular assays 

Solutions: Add sufficient amounts of phosphatase inhibitors and protease inhibitors to the lysis buffer; optimize the lysis time point after cell stimulation; use rapid and gentle cell lysis methods.

Applications: High-throughput screening, lead compound optimization, kinase profiling selectivity analysis, compound mechanism of action research, and preclinical candidate molecule function confirmation.

Trends:

1.Higher throughput and miniaturization: Developing 1536-well plates and even higher density plates, combined with non-contact dispensing techniques such as ultrasonic pipetting.

2.High content and dynamic monitoring: Combining high content imaging to analyze subcellular phosphorylation changes; developing fluorescent biosensors for real-time monitoring of kinase activity. 

3.A more physiologically accurate model: Assays are performed in lysates or cell extracts, preserving some cellular background; functional assessments are conducted using primary cells or patient-derived organoids.

4.Multi-parameter and AI integration: Combining multi-dimensional data such as biochemical activity, cell activity, and selectivity profiles, AI models are used to predict compound activity and optimization directions.

Kinase assay development is a process that begins with a clear drug discovery objective, and based on this, a strategic choice is made between the high throughput and controllability of biochemical assays and the high physiological relevance of cell assays. Successful development depends on a deep understanding of the enzymatic properties of kinases, a thorough grasp of the principles of the assay technology, and systematic optimization of every component and condition in the reaction system. A well-designed and fully optimized kinase assay is an indispensable engine for accelerating the discovery of kinase inhibitors, elucidating the mechanisms of action of compounds, and ultimately propelling candidate drugs into the development stage. Development documentation should be detailed and complete, providing a solid foundation for subsequent method validation based on the guidelines of the Chinese Pharmacopoeia.